Product Description: Sertindole-d4 is the deuterium labeled Sertindole. Sertindole, a neuroleptic, is one of the newer antipsychotic medications available[1][2].
Applications: Cancer-programmed cell death
Formula: C24H22D4ClFN4O
References: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216./[2]Juruena, M.F., E.P. de Sena, and I.R. de Oliveira, Sertindole in the management of schizophrenia. J Cent Nerv Syst Dis, 2011. 3: p. 75-85./[3]Kane, J.M. and C.A. Tamminga, Sertindole (Serdolect): preclinical and clinical findings of a new atypical antipsychotic. Expert Opin Investig Drugs, 1997. 6(11): p. 1729-41./[4]Murdoch, D. and G.M. Keating, Sertindole : a review of its use in schizophrenia. CNS Drugs, 2006. 20(3): p. 233-55.
CAS Number: 1794737-42-0
Molecular Weight: 444.97
Compound Purity: 98.64
Research Area: Neurological Disease; Cancer
Solubility: 10 mM in DMSO/DMF : ≥ 15mg/mL/DMSO : ≥ 5mg/mL
Target: 5-HT Receptor;Adrenergic Receptor;Autophagy;Dopamine Receptor;Isotope-Labeled Compounds
Deutsch
English
